RESEARCH TRIANGLE PARK, NC—Womble Bond Dickinson attorney Dr. Julie Meigs has been appointed to the North Carolina Biosciences Organization (NCBIO) Board of Directors.

Meigs has over 20 years of intellectual property experience in life sciences after beginning her career as a research scientist in the biotech industry. Her practice focuses on the design and implementation of global patent strategies, including life cycle and risk management. She advises clients in a wide range of patent-related areas, including preparation and prosecution of US and international patent applications, freedom to operate and invalidity analyses, due diligence, competitor activity, and strategic partnerships.

Formed in 1994, NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. 

NCBIO advocates for state and federal public policies that encourage the growth of life science companies, supports the development of a strong life science workforce, promotes research and technology transfer at universities and other institutions including support for capitalization and commercialization of products.

At the national level, NCBIO works with the national Biotechnology Innovation Organization, AdvaMed, PhRMA, and MDMA to support appropriate federal policies and to keep members of North Carolina’s congressional delegation informed as to the needs and priorities of the life science community.